Resection or Ablation of Small Kidney Tumors

ConditionKidney Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorKarolinska University Hospital

About this trial

Ablative treatments are believed to have a lower rate of complications, shorter hospital stays, and fewer interventions with benign PAD compared to partial nephrectomies in small kidney cancer lesions. The purpose of the study is to compare complications, the frequency of residual tumors, impact on kidney function, differences in quality of life, and health economic factors in a randomised study. We will also compare the oncological outcomes, including survival and recurrence of kidney cancer.

Eligibility criteria

Qualifiers

Age 18 - 99 years

Patient suitable based on clinical status for both ablative treatment and surgery

Primary kidney tumor

Tumor size ≤ 3 cm

Disqualifiers

Radiological signs of metastasis

Synchronous kidney tumors

ISUP grade IV or sarcomatoid growth in the biopsy

Other metastasized cancer in the last 5 years

Trial design

Treatments tested in this trial

  • Ablation
  • Surgery

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators